AbCellera Biologics Inc. (ABCL) Social Stream
ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABCL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $55 | $25 | $45.25 | $5.08 | 790.75% |
| 2021-12-05 | 5 | $53 | $25 | $40.8 | $5.08 | 703.15% |
| 2021-12-19 | 7 | $53 | $25 | $39.833 | $5.08 | 684.11% |
| 2021-12-21 | 7 | $53 | $25 | $38 | $5.08 | 648.03% |
| 2022-02-11 | 5 | $45 | $25 | $33 | $5.08 | 549.61% |
| 2022-02-25 | 5 | $40 | $20 | $30 | $5.08 | 490.55% |
| 2022-05-09 | 5 | $40 | $20 | $29.6 | $5.08 | 482.68% |
| 2022-05-11 | 5 | $32 | $14 | $24.8 | $5.08 | 388.19% |
| 2022-08-09 | 5 | $32 | $14 | $23.6 | $5.08 | 364.57% |
| 2022-08-11 | 5 | $34 | $14 | $24 | $5.08 | 372.44% |
| 2022-10-23 | 5 | $34 | $13 | $23.8 | $5.08 | 368.5% |
| 2022-11-02 | 4 | $34 | $13 | $23.6 | $5.08 | 364.57% |
| 2022-11-09 | 5 | $32 | $20 | $23.6 | $5.08 | 364.57% |
| 2022-11-30 | 6 | $32 | $20 | $24.5 | $5.08 | 382.28% |
| 2022-12-15 | 7 | $32 | $20 | $25.285 | $5.08 | 397.74% |
| 2023-01-06 | 6 | $32 | $18 | $25 | $5.08 | 392.13% |
| 2023-02-21 | 7 | $32 | $18 | $25 | $5.08 | 392.13% |
| 2023-02-22 | 7 | $32 | $18 | $25.5 | $5.08 | 401.97% |
| 2023-04-20 | 7 | $32 | $16 | $26.833 | $5.08 | 428.21% |
| 2023-05-04 | 7 | $32 | $15 | $25.833 | $5.08 | 408.52% |
| 2023-05-11 | 7 | $32 | $15 | $25.666 | $5.08 | 405.24% |
| 2023-05-26 | 7 | $32 | $15 | $26.166 | $5.08 | 415.08% |
| 2023-08-03 | 7 | $32.001 | $15 | $26.166 | $5.08 | 415.08% |
| 2023-08-07 | 7 | $32.001 | $13 | $25.833 | $5.08 | 408.52% |
| 2023-08-31 | 8 | $32 | $12 | $23 | $5.08 | 352.76% |
The Trend in the Analyst Price Target
ABCL's average price target has moved down $16.83 over the prior 21 months.
Over the past 45 weeks, ABCL's average upside potential has been 209.33%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-09 | 6 | 32.000 | 20 | 23.600 | 11.81 | 99.83% |
| 2023-02-22 | 8 | 32.000 | 18 | 26.142 | 8.79 | 197.41% |
| 2023-02-22 | 8 | 32.000 | 18 | 25.500 | 8.79 | 190.1% |
| 2023-04-20 | 7 | 32.000 | 16 | 26.833 | 7.12 | 276.87% |
| 2023-07-21 | 7 | 32.001 | 15 | 26.166 | 7.85 | 233.32% |
ABCL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 43 weeks, ABCL's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABCL has a greater upside potential (average analyst target price relative to current price) than 3600.3% of all US stocks.
- ABCELLERA BIOLOGICS INC's number of analysts covering the stock is greater than 325.16% of stocks in the large market cap category.
- ABCL has a higher average analyst price target than 619.88% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, ABCELLERA BIOLOGICS INC's variance in analysts' estimates is lower than -2774.18% of them.
In the Pharmaceutical Products industry, RVMD, BEAM, and VIR are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!